Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [9648]

Bladder cancer updates from the first half of 2026

Prof Alison Birtle, Dr Ignacio Duran, Dr Laura Mertens, Prof Morgan Rouprêt and...

Bladder cancer updates from the first half of 2026 ( Prof Alison Birtle, Dr Ignacio Duran, Dr Laura Mertens, Prof Morgan Rouprêt and Dr Patrizia Giannatempo )

Zoldonrasib plus daraxonrasib targets KRAS G12D in metastatic pancreatic cancer...

Dr Nilo Azad - Johns Hopkins University, Baltimore, USA

Zoldonrasib plus daraxonrasib targets KRAS G12D in metastatic pancreatic cancer with promising early results ( Dr Nilo Azad - Johns Hopkins University, Baltimore, USA )

The impact of disease burden: Understanding patient priorities in aRCC

Prof Thomas Powles and Dena Battle

The impact of disease burden: Understanding patient priorities in aRCC ( Prof Thomas Powles and Dena Battle )

Immune checkpoint inhibitors show setting specific benefit in ovarian cancer...

Dr Aakash Pandit - Chitwan Medical College Teaching Hospital (CMCTH), Bharatpur...

Immune checkpoint inhibitors show setting specific benefit in ovarian cancer meta analysis of 17 randomised trials ( Dr Aakash Pandit - Chitwan Medical College Teaching Hospital (CMCTH), Bharatpur, Nepal )

P-32 microparticle brachytherapy plus FOLFIRINOX shows promising local control...

Dr Michele Milella - University of Verona, Verona, Italy

P-32 microparticle brachytherapy plus FOLFIRINOX shows promising local control in unresectable pancreatic cancer ( Dr Michele Milella - University of Verona, Verona, Italy )

Therapeutic mammoplasty: An advanced oncoplastic breast surgery technique

Dr Sanjit Agrawal - Tata Medical Center, Kolkata, India

Therapeutic mammoplasty: An advanced oncoplastic breast surgery technique ( Dr Sanjit Agrawal - Tata Medical Center, Kolkata, India )

Adagrasib plus cetuximab shows activity but does not improve survival in KRAS...

Dr Josep Tabernero - Vall d'Hebron Institute of Oncology, Barcelona, Spain

Adagrasib plus cetuximab shows activity but does not improve survival in KRAS G12C-mutated metastatic colorectal cancer ( Dr Josep Tabernero - Vall d'Hebron Institute of Oncology, Barcelona, Spain )

Zolbetuximab plus chemo in CLDN18.2-positive metastatic pancreatic cancer does...

Dr Wungki Park - Memorial Sloan Kettering Cancer Center, New York, USA

Zolbetuximab plus chemo in CLDN18.2-positive metastatic pancreatic cancer does not improve OS ( Dr Wungki Park - Memorial Sloan Kettering Cancer Center, New York, USA )

ctDNA MRD status predicts survival and adjuvant chemo benefit in resected...

Dr Kozo Kataoka - Hyogo Medical University, Nishinomiya, Japan

ctDNA MRD status predicts survival and adjuvant chemo benefit in resected colorectal liver metastas ( Dr Kozo Kataoka - Hyogo Medical University, Nishinomiya, Japan )

Talquetamab plus daratumumab with or without pomalidomide improves PFS in r/r...

Dr Peter Voorhees - Atrium Health Levine Cancer Institute, Charlotte, USA

Talquetamab plus daratumumab with or without pomalidomide improves PFS in r/r multiple myeloma ( Dr Peter Voorhees - Atrium Health Levine Cancer Institute, Charlotte, USA )

Defining breast cancer quality care around the globe

Dr Didier Verhoeven, Prof Sabine Siesling, Prof Pankaj Gupta Roy & Prof Cary...

Defining breast cancer quality care around the globe ( Dr Didier Verhoeven, Prof Sabine Siesling, Prof Pankaj Gupta Roy & Prof Cary Kaufman )

Global oncology innovations: B.J. Kennedy award for geriatric oncology

Dr Enrique Soto Pérez de Celis - University of Colorado Cancer Center, Aurora...

Global oncology innovations: B.J. Kennedy award for geriatric oncology ( Dr Enrique Soto Pérez de Celis - University of Colorado Cancer Center, Aurora, USA )

More from ecancer